Cargando…
De-identified data quality assessment approaches by data vendors who license data to healthcare and life sciences researchers
OBJECTIVE: To gain insights into how data vendor companies (DVs), an important source of de-identified/anonymized licensed patient-related data (D/ALD) used in clinical informatics research in life sciences and the pharmaceutical industry, characterize, conduct, and communicate data quality assessme...
Autores principales: | Erwin Johnson, C, Colquhoun, Daniel, Ruppar, Daniel A, Vetter, Sascha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629893/ https://www.ncbi.nlm.nih.gov/pubmed/36339052 http://dx.doi.org/10.1093/jamiaopen/ooac093 |
Ejemplares similares
-
Characterizing physician EHR use with vendor derived data: a feasibility study and cross-sectional analysis
por: Melnick, Edward R, et al.
Publicado: (2021) -
The EBI RDF platform: linked open data for the life sciences
por: Jupp, Simon, et al.
Publicado: (2014) -
Leveraging Devices, Data and Discovery for Smarter Healthcare in Japan
por: Sawa, Tomohiro
Publicado: (2011) -
Framework for identifying drug repurposing candidates from observational healthcare data
por: Ozery-Flato, Michal, et al.
Publicado: (2020) -
Bioclipse-R: integrating management and visualization of life science data with statistical analysis
por: Spjuth, Ola, et al.
Publicado: (2013)